期刊文献+

2型糖尿病大鼠模型的建立与评价 被引量:37

Establishment and Evaluation of Rat Models of Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的:建立具有胰岛素抵抗特征、发病过程近似于人类2型糖尿病的动物模型。方法:雄性Wistar大鼠喂以富含不饱和脂肪酸的特殊高脂肪膳食5周,诱发出胰岛素抵抗,继之以小剂量链脲佐菌素(STZ,25mg/kg,腹腔注射)导致胰岛素代偿性分泌障碍,诱发高血糖症。应用正常血糖-高血浆胰岛素钳夹技术评价大鼠的胰岛素敏感性。结果:与常规饲料喂养大鼠相比,高脂膳食组的葡萄糖输注率显著降低,空腹血浆胰岛素显著升高。STZ注射后1周高脂膳食组大鼠血糖中度升高,血胰岛素下降,但仍高于普通饲料喂养组,且高脂血症和胰岛素抵抗继续存在。高脂饲料喂养组及高脂饲料+小剂量STZ注射组大鼠的葡萄糖输注率显著低于正常对照组。结论:通过高脂膳食结合小剂量STZ注射成功复制出了实验性2型糖尿病动物模型,它是研究2型糖尿病发病机制、药物研究和胰岛素抵抗相关疾病的理想动物模型。 Objective: To establish an animal model similar to the metabolic abnormalities of human type 2 diabetes mellitus with insulin resistance.MethodS: Adult male Wistar rats were fed with high-fatty (59% of calories-fat) diet that contained unsaturated fatty acid for 5 weeks to induce insulin resistance, then streptozotion(STZ, 25 mg/kg) was injected intraperitoneally to result in insulin secretion defect and hyperglycemia, euglycemic-hyperinsulincmic clamp technique was performed in rats to estimate their insulin sensitivity.Results: Glucose infusion rates (GIR) in the rats with high-fat diet decreased and fast plasma insulin increased compared with the control group. Based on the high-fat diet, the rats were injected intraperitoneally with lowdose streptozotocin to establish type 2 diabetes mellitus model. One week after STZ injection,blood glucose moderate increased, plasma insulin decreased but still higher than that in regular chow-fed rats, with insulin resistance and dyslipidemia still existed. GIR was obviously lower in rats with the high-fatty diet group and the high fatty plus low dose STZ injection group than that of the control group. Conclusion; Type 2 diabetes mellitus animal model is successfully reproduced by using the high fatty diet plus low dose STZ injection.It may provide a perfect animal model for investigating type 2 diabetic mechanism and pharmacology, also be used to research insulin resistance and related diseases of human beings.
出处 《天津医药》 CAS 北大核心 2006年第1期33-35,共3页 Tianjin Medical Journal
基金 重庆市自然科学基金资助项目(项目编号20038012)
关键词 糖尿病 2型疾病模型 动物 胰岛素抗药性 链脲菌素 diabetes mellitus,type 2 disease models,animal insulin resistance streptozocin
  • 相关文献

参考文献8

  • 1Krentz AJ,Bailey CJ.Oral antidiabetic agents:current role in type 2diabetes mellitus.Drugs,2005,65(3):385-411.
  • 2李晨钟,张素华,舒昌达,任伟.用高脂肪膳食复制胰岛素抵抗大鼠模型[J].基础医学与临床,2000,20(3):93-95. 被引量:45
  • 3Pereira AM,Biermasz NR,Roelfsema F,et al.A pharmacologic therapies for acromegaly:a review of their effects on glucose metabolism and insulin resistance.Treatments Endocrinol,2005,4(1):43-53.
  • 4Tenenbaum A,Motro M,Fisman EZ,et al.Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.Circulation,2004,109(18):2197-2202.
  • 5高志强,陆付耳.游离脂肪酸、胰岛素抵抗与非酒精性脂肪性肝炎[J].世界华人消化杂志,2003,11(7):1043-1045. 被引量:15
  • 6Bergman RN.Non-esterified fatty acids and the liver.Why is insulin secreted into the portal vein? Diabetologia,2000,43:946-952.
  • 7Unger RH.Lipotoxic diseases.Annu Rev Med,2002,53:319-336.
  • 8Talpur N,Echard B,Ingram C,et al.Effects of a novel formulation of essential oils on glucose-insulin metabolism in diabetic and hypertensive rats:a pilot study.Diabetes Obes Metab,2005,7(2):193-199.

二级参考文献32

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2Crespo J, Cayón A, Fernàndez-Gil P, Hernandez-Guerra M,Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, Pons-Romero F. Gene expression of tumor necrosis factor-α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.Hepatology 2001;34:1185-1163.
  • 3Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzmàn M,Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidationvia protein kinase A. J Biol Chem 2001;276:25096-25100.
  • 4Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Liddle C,Samarasinghe D, George J. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 2002;36:403-409.
  • 5Gabriely I, Ma XH, Yang XM, Rossetti L, Barzilai N. Leptin resistance during aging is independent of fat mass. Diabetes 2002;51:1016-1021.
  • 6Nakatani T, Tsuboyama-Kasaoka N, Takahashi M, Miura S,Ezaki O. Mechanism for peroxisome proliferator-activated re-ceptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes. J Biol Chem 2002;277:9562-9569.
  • 7Huang X, Eriksson KF, Vaag A, Lehtovirta M, Hansson M,Laurila E, Kanninen T, Olesen BT, Kurucz I, Koranyi L, Groop L. Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes 1999;48:1508-1514.
  • 8Patrick L. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev 2002;7:276-301.
  • 9Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.Nutr Rev 2002;60:289-303.
  • 10Diehl AM. Nonalcoholic steatohepatitis. Semin Liver Dis 1999;19:221-230.

共引文献58

同被引文献275

引证文献37

二级引证文献357

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部